Publication
Bank of England warns against counteracting regulatory capital requirements
United Kingdom | Publication | April 2022
The Bank of England has warned PRA-regulated firms not to structure deficit reduction transactions so as to “limit the regulatory capital impact that would otherwise result.”
The press release, issued on April 13, 2022, says that the Bank is aware that some PRA-regulated firms have conducted or may be considering conducting such transactions with their DB pension schemes. It warns them against this and points to the risks of such transactions, including that “(…) they can have the effect of overestimating eligible capital or reducing capital requirements, without commensurately reducing the risk in the financial system, thus undermining the calibration of minimum regulatory capital requirements.”
This is a reminder to banks and insurance companies to tread carefully when seeking to optimise their accounting treatment for DB pension assets and liabilities. The Bank of England clearly disapproves of any payment structure that could be seen as trying to artificially reduce or defer regulatory capital requirements.
Recent publications
Publication
The GCR Guide to Life Sciences – Product denigration
Marta Giner Asins and Arnaud Sanz of our Paris office are the authors of a chapter on product denigration that has been published in the third edition of the Global Competition Review’s The Guide to Life Sciences.
Publication
The GCR Guide to Life Sciences – Merger control: Procedural issues
Miranda Cole, Julien Haverals and Emma Clarke of our Brussels/ London offices are the authors of a chapter on procedural issues in merger control that has been published in the third edition of the Global Competition Review’s The Guide to Life Sciences. This covers a number of significant procedural developments that have affected merger review of life sciences transactions.
Subscribe and stay up to date with the latest legal news, information and events . . .